Coagulatory Defects in Type-1 and Type-2 Diabetes

Int J Mol Sci. 2019 Dec 16;20(24):6345. doi: 10.3390/ijms20246345.

Abstract

Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of death for individuals with diabetes is cardiovascular diseases, in part since both types of diabetes lead to physiological changes that affect haemostasis. Those changes include altered concentrations of coagulatory proteins, hyper-activation of platelets, changes in metal ion homeostasis, alterations in lipid metabolism (leading to lipotoxicity in the heart and atherosclerosis), the presence of pro-coagulatory microparticles and endothelial dysfunction. In this review, we explore the different mechanisms by which diabetes leads to an increased risk of developing coagulatory disorders and how this differs between type-1 and type-2 diabetes.

Keywords: atherosclerosis; endothelial dysfunction; magnesium; metal ions; microparticles; platelets; thrombosis; zinc.

Publication types

  • Review

MeSH terms

  • Blood Coagulation
  • Blood Coagulation Disorders / blood*
  • Blood Coagulation Disorders / complications*
  • Blood Coagulation Disorders / therapy
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications*
  • Humans
  • Lipid Metabolism
  • Risk Factors